# Analgesic Treatment Mediated by Arcoxia (0663-093)

> **NCT00380523** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 237 (estimated)

## Conditions studied

- Pain

## Interventions

- **DRUG:** MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days

## Key facts

- **NCT ID:** NCT00380523
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 237 (ESTIMATED)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380523, "Analgesic Treatment Mediated by Arcoxia (0663-093)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00380523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*